GlyCLICK®: A Precise & Versatile Conjugation Platform for Improved ADCs

  • Showcasing GlyCLICK® site-specific conjugation that produces homogeneous ADCs with a defined drug-to-antibody ratio while preserving antibody function
  • Exploring how the platform supports controlled ADC generation and applies to a wide range of antibody formats and payloads
  • Laying out case studies and preclinical examples demonstrate how GlyCLICK® is used in the development of novel ADCs